Cony-Makhoul Pascale

Cony-Makhoul Pascale

Hématologie

Lysarc
Pierre-Bénite, France

146 Activités

291 Followers

Scientifique

Digital

Production scientifique

Activités par an

Expertise

Sujets de recherche

Leucémie myéloïde chronique BCR-ABL positive Leucémies Leucémie myéloïde Syndromes myélodysplasiques Leucémie myéloïde en phase chronique Lymphomes Myélofibrose primitive Myélome multiple Syndromes myéloprolifératifs

Collaborateurs

Voir plus

Nicolini Franck

Centre Léon-Bérard, Lyon, France

Legros Laurence

Hôpital Paul Brousse, Villejuif, France

Etienne Gabriel

Institut Bergonié, Bordeaux, France

Rousselot Philippe

Hôpital Saint-Louis, Paris, France

Industries

Voir plus

Pfizer

7 collaboration(s)

Dernière en 2022

Novartis

3 collaboration(s)

Dernière en 2020

Sanofi

2 collaboration(s)

Dernière en 2022

Amgen

1 collaboration(s)

Dernière en 2020

Dernières activités

Voir plus

Characteristics, Outcomes, Tfr Rates in Young Adults with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era: A French Observational Study

65th ASH Annual Meeting Abstracts 02 novembre 2023

Impact of Cytoreductive Drugs upon Outcomes in a Contemporary Cohort of Adolescent and Young Adults with Essential Thrombocythemia and Polycythemia Vera

65th ASH Annual Meeting Abstracts 02 novembre 2023

CD19-Targeting CAR T-Cell Therapy in Transformed Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma: A Descar-T and US Collaborative Study

65th ASH Annual Meeting Abstracts 02 novembre 2023

Real World Data of Axicabtagene Ciloleucel As Second Line Therapy for Patients with Large B Cell Lymphoma: First Results of a Lysa Study from the French Descar-T Registry

65th ASH Annual Meeting Abstracts 02 novembre 2023

Marsun, a Phase III, Multicenter, Open Label, Randomized, Controlled Study Investigating Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients with Relapsed or Refractory Marginal Zone Lymphoma (R/R MZL)

65th ASH Annual Meeting Abstracts 02 novembre 2023

Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort.

Blood advances 24 octobre 2023

First-line second generation tyrosine kinase inhibitors in patients with newly diagnosed accelerated phase chronic myeloid leukemia.

Leukemia research 09 mai 2023

Efficacy and safety of nilotinib in chronic myeloid leukaemia patients who failed to achieve a treatment-free remission period after imatinib discontinuation: Results of the French Nilo post-STIM study.

British journal of haematology 02 avril 2023

Long-term excess mortality and net survival among elderly diffuse large B-cell lymphoma patients after front-line R-CHOP treatment.

British journal of haematology 22 février 2023

Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study.

American journal of hematology 01 janvier 2023